Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (11)

2018

  1. Mutations in the JAK/STAT pathway genes and activation of the pathway, a relevant finding in nodal Peripheral T-cell lymphoma

    British Journal of Haematology

2014

  1. Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: A clinicopathological study

    Modern Pathology, Vol. 27, Núm. 2, pp. 281-293

  2. The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature

    Blood

2013

  1. MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma

    British Journal of Haematology, Vol. 162, Núm. 3, pp. 336-347

  2. Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas

    Haematologica, Vol. 98, Núm. 1, pp. 57-64

2011

  1. Improved demonstration of immunohistochemical prognostic markers for survival in follicular lymphoma cells

    Modern Pathology, Vol. 24, Núm. 5, pp. 698-707

2010

  1. Amolecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

    Blood, Vol. 116, Núm. 8

2008

  1. Erratum: Frequency of BCL2 and BCL6 translocations in follicular lymphoma: Relation with histological and clinical features (Leukemia and Lymphoma (2008) vol. 49(1) (95-101))

    Leukemia and Lymphoma

2003

  1. The Molecular Signature of Mantle Cell Lymphoma Reveals Multiple Signals Favoring Cell Survival

    Cancer Research, Vol. 63, Núm. 23, pp. 8226-8232

2000

  1. Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin's disease treated with chemotherapy

    Leukemia and Lymphoma, Vol. 39, Núm. 5-6, pp. 563-572

1999

  1. Other cancers in patients with gastric MALT lymphoma

    Leukemia and Lymphoma, Vol. 33, Núm. 1-2, pp. 161-168